Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer

Figure 2

Frequency of MCTs and CD147 expressions in normal prostate, non-neoplastic, PIN lesions and tumour samples. In general, there is an increase in both MCT2 and MCT4 expressions from non-neoplastic (normal or adjacent) to tumour tissues, while a decrease is observed for MCT1 and CD147 expression in the transition from non-neoplastic (normal or adjacent) to prostate tumour tissue. See text for detail. * p < 0.05 (non-neoplastic adjacent, PIN and tumour tissue compared to normal tissue).

Back to article page